glutathione bladder infection Frontiers In Vitro and In Vivo
Description
Neither has large-scale long-term randomized controlled trial data for skin brightening as a primary endpoint
Arq Gastroenterol
Patients should not assume a particular outcome from this treatment
Common adverse events include headache, dizziness, and injection site reactions
In a Phase I study, one patient who received HSPCs via a hepatic artery developed radiocontrast nephropathy, rapidly progressed to type I hepatorenal syndrome, and died of liver failure before undergoing urgent liver transplantation [61]
